Triple therapy with glimepiride in patients with type 2diabetes mellitus inadequately controlled by metformin and a thiazolidinedione: Results of a 30-week, randomized, double-blind, placebo-controlled, parallel-group study-Reference-Cited by-同舟云学术

Triple therapy with glimepiride in patients with type 2diabetes mellitus inadequately controlled by metformin and a thiazolidinedione: Results of a 30-week, randomized, double-blind, placebo-controlled, parallel-group study

Published:2005-10 Issue:10 Volume:27 Page:1535-1547
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Roberts Victor Lawrence,Stewart John,Issa Maher,Lake Barbara,Melis Robert

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference38 articles.

1. Optimal glycemic control in type 2 diabetes mellitus: Fasting and postprandial glucose in context;Abrahamson;Arch Intern Med,2004

2. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type2 diabetes (UKPDS 33);Lancet,1998

3. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: Progressive requirement for multipletherapies (UKPDS 49);Turner;JAMA,1999

4. Combination therapy for type 2 diabetes;Mudaliar;Endocr Pract,1999

5. A comparison of acarbose versus metformin as an adjuvant therapy in sulfonylurea-treated NIDDM patients;Bayraktar;Diabetes Care,1996

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Review on Affordable Combinations in Type 2 Diabetes Care: Exploring the Cost-Effective Potential of Glipizide + Metformin and Glimepiride + Metformin + Pioglitazone;Cureus;2024-05-07

2. Time to reposition sulfonylureas in type 2 diabetes management in Indian context: A pragmatic practical approach;International Journal of Diabetes in Developing Countries;2023-04-19

3. Fixed-Dose Combination of Dipeptidyl Peptidase-4 Inhibitors Plus Metformin in Patients with Type 2 Diabetes: A Review on Safety and Efficacy;Journal of Pharmaceutical Research International;2021-12-03

4. Age, sex, disease severity, and disease duration difference in placebo response: implications from a meta-analysis of diabetes mellitus;BMC Medicine;2020-11-16

5. Identification of the minimum non-inferior dose in a three-arm non-inferiority trial;Journal of the Korean Statistical Society;2020-02-18